IP Verse

The Regents Of The University Of California patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of The Regents Of The University Of California opposed by its competitors

Explore The Regents Of The University Of California's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3250693
Dec 20, 2023Protein Delivery In Primary Hematopoietic Cells1
EP3495822
Dec 20, 2023Method For Assessing Acute Myocardial Infarction Based On Highly Sensitive Analysis Of Cardiac Troponin1
EP3597749
Jul 26, 2023Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription3
EP2906696
Dec 14, 2022Methods For Modulating C9Orf72 Expression2
EP1793855
Jan 19, 2022Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease1
EP3615667
Aug 11, 2021Microorganisms And Methods For Producing Cannabinoids And Cannabinoid Derivatives2
EP3604339
Mar 10, 2021Therapeutic Antibodies Against Ror-1 Protein And Methods For Use Of Same1
EP2328553
Jun 10, 2020Corticosteroids For The Treatment Of Inflammatory Diseases Of The Gastrointestinal Tract1
EP2535044
Dec 18, 2019Enterically Coated Cysteamine, Cystamine And Derivatives Thereof1
EP2709672
Dec 18, 2019Compositions And Methods For Treating Retinal Diseases1

Top competitors of The Regents Of The University Of California

List of top competitors of The Regents Of The University Of California based on patent oppositions.